BioGnost is an internationally recognized company and regional leader in the development and manufacture of in vitro medical diagnostic devices, especially diagnostic reagents used in histopathology, cytology, hematology, and microbiology. The company manufactures diagnostic reagents according to implemented ISO 13485:2016, ISO 9001:2015, and ISO 14001:2015 standards, and all the products bear the CE mark. Our product portfolio currently contains over 2000 highly standardized and high-quality products that are the results of continuous investment in research and development activities of the company and own manufacturing procedures. The company successfully commercializes and sells its products on a global level and exports to over 70 countries by cooperating with over 100 specialized distributors.
There is no investment information
No recent news or press coverage available for BioGnost Ltd..
We care about your data, and we'd love to use cookies make your experience better.
